Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
KIT
Description:
A receptor tyrosine kinase encoded by the KIT gene, involved in cell growth and development and studied as an oncogene and cancer target.
Related topic:
Gastrointestinal Tumor Research and Treatment (17%)
OpenAlex ID:
keywords/kit
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
1997
·
Motonari Kondo
, Irving L. Weissman
, et al.
·
Cell
·
2,374
PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors
2003
·
Michael C. Heinrich
, Christopher L. Corless
, et al.
·
Science
·
2,347
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
2009
·
Ronald P DeMatteo
, Karla V Ballman
, et al.
·
The Lancet
·
1,399
Regorafenib (BAY 73‐4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
2010
·
Scott M. Wilhelm
, Jacques Dumas
, et al.
·
International Journal of Cancer
·
1,390
PDF
Gastrointestinal Stromal Tumors of the Stomach: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 1765 Cases With Long-term Follow-up
2004
·
Markku Miettinen
, Leslie H Sobin
, et al.
·
The American Journal of Surgical Pathology
·
1,270
Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study
2001
·
Allan T van Oosterom
, Ian Judson
, et al.
·
The Lancet
·
1,253
The role of microRNA genes in papillary thyroid carcinoma
2005
·
Huiling He
, Krystian Jazdzewski
, et al.
·
Proceedings of the National Academy of Sciences
·
1,228
Integrated signalling pathways for mast-cell activation
2006
·
Alasdair M. Gilfillan
, Christine Tkaczyk
·
Nature reviews. Immunology
·
990
KIT as a Therapeutic Target in Metastatic Melanoma
2011
·
Richard D. Carvajal
, Cristina R Antonescu
, et al.
·
JAMA
·
905
Sunitinib: From Rational Design to Clinical Efficacy
2007
·
Laura Q.M. Chow
, S. Gail Eckhardt
·
Journal of Clinical Oncology
·
899
Gastrointestinal Stromal Tumors, Intramural Leiomyomas, and Leiomyosarcomas in the Rectum and Anus: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 144 Cases
2001
·
Markku Miettinen
, Mary Furlong
, et al.
·
The American Journal of Surgical Pathology
·
733
Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3
2008
·
Dana D. Hu-Lowe
, Helen Y. Zou
, et al.
·
Clinical Cancer Research
·
659
Gastrointestinal Stromal Tumors of the Jejunum and Ileum: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 906 Cases Before Imatinib With Long-term Follow-up
2006
·
Markku Miettinen
, Hala Makhlouf
, et al.
·
The American Journal of Surgical Pathology
·
657
SU11248 inhibits KIT and platelet-derived growth factor receptor beta in preclinical models of human small cell lung cancer.
2003
·
Tinya J Abrams
, Leslie B Lee
, et al.
·
PubMed
·
636
Revealing the complex genetic architecture of obsessive–compulsive disorder using meta-analysis
2017
·
IOCDF-GC
, OCGAS
·
Molecular Psychiatry
·
611
PDF
Molecular characterisation of soft tissue tumours: a gene expression study
2002
·
Torsten O Nielsen
, Rob B West
, et al.
·
The Lancet
·
571
Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers
2018
·
Nikita Pozdeyev
, Laurie M. Gay
, et al.
·
Clinical Cancer Research
·
564
KIT (CD117): A Review on Expression in Normal and Neoplastic Tissues, and Mutations and Their Clinicopathologic Correlation
2005
·
Markku Miettinen
, Jerzy Lasota
·
Applied immunohistochemistry & molecular morphology
·
564
Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases
2005
·
Todd A. Carter
, Lisa M. Wodicka
, et al.
·
Proceedings of the National Academy of Sciences
·
557
The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues
2002
·
Maria G. Minasi
, Mara Riminucci
, et al.
·
Development
·
521
Phase II Study of Sunitinib Malate, an Oral Multitargeted Tyrosine Kinase Inhibitor, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
2008
·
Harold J. Burstein
, Anthony D. Elias
, et al.
·
Journal of Clinical Oncology
·
495
PDF
Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001–2020)
2020
·
Liling Huang
, Shiyu Jiang
, et al.
·
Journal of Hematology & Oncology
·
490
PDF
Antitumor Activity of Lenvatinib (E7080): An Angiogenesis Inhibitor That Targets Multiple Receptor Tyrosine Kinases in Preclinical Human Thyroid Cancer Models
2014
·
Osamu Tohyama
, Junji Matsui
, et al.
·
Journal of Thyroid Research
·
489
PDF
Dasatinib (BMS-354825), a Dual SRC/ABL Kinase Inhibitor, Inhibits the Kinase Activity of Wild-Type, Juxtamembrane, and Activation Loop Mutant KIT Isoforms Associated with Human Malignancies
2006
·
Marcus M. Schittenhelm
, Sharon Shiraga
, et al.
·
Cancer Research
·
477
Developmental model for the pathogenesis of testicular carcinoma in situ : genetic and environmental aspects
2006
·
Ewa Rajpert-De Meyts
·
Human Reproduction Update
·
463
Show more works
View as search
Works count:
4,767
Citation count:
112,700
Year
Topic
Type